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Abstract 
Galβ1-4GlcNAc is thought to be a common disaccharide unit preferentially recognized by 
vertebrate galectins. Eight amino acid residues conserved in proteins belonging to the galectin 
family have been suggested to be responsible for recognition. Meanwhile, we isolated and 
analyzed endogenous N-glycans of Caenorhabditis elegans that were captured by a C. elegans 
galectin LEC-6, and demonstrated that the unit of recognition for LEC-6 is a Gal-Fuc 
disaccharide, though the linkage between these residues was not confirmed. In the present 
study, we chemically synthesized Galβ1-4Fuc and Galβ1-3Fuc labeled with 2-aminopyridine 
(PA), and demonstrated that LEC-6 interacts with PA-Galβ1-4Fuc more strongly than 
PA-Galβ1-3Fuc by frontal affinity chromatography (FAC). Galβ1-4Fuc also inhibited 
hemagglutination caused by LEC-6 more strongly than Galβ1-3Fuc. FAC analysis using 
LEC-6 point mutants revealed that some of the conserved amino acid residues which have 
proved to be important for recognition of Galβ1-4GlcNAc are not necessary for the binding to 
Galβ1-4Fuc. Another major C. elegans galectin, LEC-1, also showed preferential binding to 
Galβ1-4Fuc. These results suggest that Galβ1-4Fuc is the endogenous unit structure 
recognized by C. elegans galectins, which implies that C. elegans glycans and galectins may 
have co-evolved through an alteration in the structures of C. elegans glycans and a subsequent 
conversion in the sugar-binding mechanism of galectins. Furthermore, since glycans 
containing the Galβ1-4Fuc disaccharide unit have been found in organisms belonging to 
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Protostomia, this unit might be a common glyco-epitope recognized by galectins in these 
organisms.  
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Introduction 
Galectins are a family of lectins distributed in animals and fungi (Kasai and Hirabayashi, 
1996; Cooper, 2002; Vasta et al., 2004). They play roles in various biological phenomena 
including development, immunity, and tumor metastasis, via recognition of cell-surface 
glycoconjugates having β-galactosides (Rabinovich et al., 2007). A Galβ1-4GlcNAc 
(N-acetyllactosamine) disaccharide unit is thought to be the endogenous glyco-epitope 
recognized by vertebrate galectins. Such ability has also been found in galectins from 
invertebrate species including Caenorhabditis elegans, and well-conserved 8 amino acid 
residues of galectins have proved to be important for their N-acetyllactosamine-binding 
ability (Lobsanov et al., 1993; Hirabayashi, et al., 2002; Pace et al., 2002; Vasta et al., 2004; 
Nemoto-Sasaki et al., 2008). In the genome of C. elegans, over 10 galectin genes have been 
assigned by database search (designated as lec-1 to lec-11 and DC2.3a) (Nemoto-Sasaki et al., 
2008). We have already isolated the products of two of them, LEC-1 and LEC-6, from the 
worm body, and produced four other products as recombinant proteins (Hirabayashi, Satoh, 
Ohyama and Kasai, 1992; Hirabayashi, Satoh and Kasai, 1992; Hirabayashi et al., 1996; Arata 
et al. 2001; Hirabayashi et al., 2002; Nemoto-Sasaki et al., 2008). However, existence of the 
glycan containing N-acetyllactosamine units has not been confirmed in C. elegans (Guerardel 
et al., 2001; Schachter, 2004; Cipollo et al., 2005; Griffitts et al., 2005; Hanneman et al., 
2006; Paschinger et al., 2008). This discrepancy raises a question: What is the endogenous 
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glyco-epitope that is recognized by C. elegans galectins? 
Recently, we isolated N-type glycoproteins captured by C. elegans galectin LEC-6, 
and analyzed their sugar structure by mass spectrometry (MALDI-TOF/TOF analysis in 
conjunction with glycosidase digestion); we found that LEC-6 interacts strongly with 
N-glycans containing a Gal-Fuc disaccharide unit attached to position 6 of the innermost 
GlcNAc residue (Takeuchi, Hayama et al., 2008). The linkage between galactose and fucose 
residues remained undetermined, because it was difficult to reveal by MS analysis. A β1-4 
linkage is more likely, because the presence of Galβ1-4Fuc has been reported in C. elegans 
N-glycans (Hanneman et al., 2006; Gutternigg et al., 2007), but the possibility of Galβ1-3Fuc 
cannot be excluded because of its similarity in conformation to Galβ1-4Glc (lactose).  
In the present study, we compared the binding strengths of chemically synthesized 
Galβ1-4Fuc and Galβ1-3Fuc to LEC-6 by frontal affinity chromatography (FAC) analysis 
(Kasai et al., 1986). We used an immobilized LEC-6 column and fluorescence-labeled 
Galβ1-4Fuc and Galβ1-3Fuc; these disaccharides were conjugated with 2-aminopyridine (PA) 
via a spacer derived from mannitol (Fig. 1). Retardation of PA-Galβ1-4Fuc was significantly 
larger than that of PA-Galβ1-3Fuc. It was also found that hemagglutination caused by LEC-6 
was inhibited more strongly by non-labeled Galβ1-4Fuc than by Galβ1-3Fuc. These 
observations support the assumption that Galβ1-4Fuc is the endogenous glyco-epitope present 
in C. elegans N-glycans. Furthermore, from experiments using LEC-6 point mutants, we 
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found that some amino acid residues of LEC-6 responsible for the binding of Galβ1-4Fuc are 
not the same as those for binding of Galβ1-4GlcNAc. LEC-1, another major galectin of C. 
elegans, was also shown to preferentially bind Galβ1-4Fuc. 
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Results 
C. elegans galectin LEC-6 interacts with Galβ1-4Fuc more strongly than with Galβ1-3Fuc 
In order to examine the structure of the endogenous glyco-epitope recognized by the C. 
elegans galectin LEC-6, we chemically synthesized Galβ1-4Fuc and Galβ1-3Fuc, and labeled 
them with the fluorophore 2-aminopyridine (PA), which is indispensable to monitor the 
elution profile when FAC analysis is performed, via an appropriate spacer derived from 
mannitol. The PA-sugars thus obtained, namely, PA-Galβ1-4Fuc and PA-Galβ1-3Fuc (Fig. 1) 
were subjected to FAC analysis by using an immobilized LEC-6 column. For comparison, E3, 
an endogenous ligand oligosaccharide labeled with PA, which was derived from C. elegans 
N-glycan trapped by a high capacity LEC-6 Sepharose column and whose structure was 
determined by MS analysis previously (Takeuchi, Hayama et al., 2008), was also subjected to 
FAC analysis. Fig. 2A shows the elution profiles of each PA-sugar. The extent of retardation 
of the elution front compared with that of PA-rhamnose, which has no affinity for LEC-6, is 
proportional to the binding constant of each PA-sugar. The elution fronts of Galβ1-4Fuc, 
Galβ1-3Fuc, and E3 showed evident retardation. Ka and Kd values calculated for the 
LEC-6-PA-sugar complex are shown in Fig. 2B. E3 was shown to have the strongest affinity. 
The Ka value for Galβ1-4Fuc was lower than that for E3, but it was 4-fold higher than that for 
Galβ1-3Fuc.  
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These results suggest that Galβ1-4Fuc, but not Galβ1-3Fuc, is the endogenous 
disaccharide unit of recognition that preferentially interacts with LEC-6. It was also suggested 
that in the case of the oligosaccharide E3, portions other than the Galβ1-4Fuc moiety 
contribute to the binding. We also examined the ability of the corresponding synthesized 
sugars (not fluorescence-labeled) to inhibit hemagglutination caused by LEC-6 (Fig. 2C). The 
observed minimum concentrations required for inhibition of hemagglutination were as 
follows: Galβ1-4Fuc, 2.5 mM; Galβ1-3Fuc, 10.0 mM; and Galβ1-4Glc, 5.0 mM. Galβ1-4Fuc 
was 4 times stronger than Galβ1-3Fuc.This also supports that Galβ1-4Fuc, not Galβ1-3Fuc, 
should be the endogenous glyco-epitope recognized by LEC-6. 
 
Amino acid residues of LEC-6 responsible for the recognition of Galβ1-4Fuc are not the same 
as those of Galβ1-4GlcNAc (or Galβ1-4Glc) 
The 8 amino acid residues well conserved among the galectin family were shown to be 
important for the recognition of N-acetyllactosamine (Hirabayashi and Kasai, 1991; Lobsanov 
et al., 1993; Hirabayashi et al., 2002). They are also conserved in LEC-6 (Fig. 3A), which is 
able to bind glycans containing Galβ1-4GlcNAc (Hirabayashi et al., 1996; Hirabayashi et al., 
2002). However, the above results showed that LEC-6 recognizes Galβ1-4Fuc more strongly. 
Since Galβ1-4Fuc and Galβ1-4GlcNAc (or Galβ1-4Glc) are different from chemical and 
conformational viewpoints (Fig. 3B and C), it is possible that the mechanism of recognition of 
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Galβ1-4Fuc by LEC-6 is different from that of Galβ1-4GlcNAc by vertebrate galectins. To 
test this possibility, we substituted each one of the 8 conserved amino acid residues of LEC-6 
and expressed each point mutant as FLAG-tagged recombinant protein in Escherichia coli. 
Three of them (N62, E83, and R85) correspond to the residues essential for 
Galβ1-4GlcNAc-binding ability in the case of human galectin-1 (Hirabayashi and Kasai, 
1991) (Fig. 3A). The extract of E. coli was applied to an asialofetuin Sepharose column. 
Following extensive washing of the column, the bound protein was specifically eluted with 
lactose (Fig. 4).  
In the case of wild-type LEC-6 (WT), most of the recombinant protein was detected 
in lactose-eluted fractions (Fig. 4A, fraction 14 and 15), though some portion was detected 
both in follow-through fractions (fraction 1–4) and in retarded fractions (fraction 5–13). On 
the other hand, most LEC-6 point mutants were detected in retarded fractions, except the 
N62D and R64H mutants. N62D was mainly detected in lactose-eluted fractions, though its 
recovery in the eluted fractions seemed slightly smaller than that of WT (data not shown). In 
contrast, R64H was detected almost exclusively in follow-through fractions. These results 
suggest that substitution of each one of the 8 amino acid residues resulted more or less in the 
reduction of binding ability to the glycan parts of asialofetuin, that is, these residues of LEC-6 
are also important for the recognition of Galβ1-4GlcNAc, as in the case of vertebrate 
galectins. 
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 Next, in order to obtain quantitative data, we performed frontal affinity 
chromatography (FAC) using columns packed with immobilized point mutants on Sepharose. 
We recovered fractions from asialofetuin affinity chromatography containing each point 
mutant (except R64H mutant since it showed no retardation) (Fig. 4) and immobilized each 
mutant protein on NHS-activated Sepharose. FAC analysis was performed by applying 
fluorescence-labeled sugars to these immobilized mutant LEC-6 columns. The Ka and Kd 
values obtained are shown in Fig. 5 and Table I. The Ka values of LEC-6 point mutants for 
sugars containing Galβ1-4GlcNAc units (NA2, NA3, and NA4) were found to be 
significantly lower in comparison with WT. Therefore, these conserved residues seem to be 
important for the recognition of Galβ1-4GlcNAc. However, though H60F and E83Q have 
little or no affinity for sugars containing Galβ1-4Fuc (E3 and PA-Galβ1-4Fuc), N62D and 
V71A were found to retain affinity for these sugars. N73D, W80F, and R85H have reduced 
affinity for E3, but they retain almost similar affinity for Galβ1-4Fuc. 
These results suggest that these 8 conserved residues function differently when the 
counterpart is Galβ1-4GlcNAc or Galβ1-4Fuc. His60 and Glu83 seem to be important for the 
binding of Galβ1-4Fuc. The others residues seem to be important for the binding of 
Galβ1-4GlcNAc but not of Galβ1-4Fuc. Since the Ka value of the R85H mutant for E3 was 
lower than that for Galβ1-4Fuc, such a mutation seems to cause hindrance to the interaction 
with a portion of E3 other than the Galβ1-4Fuc moiety. In the cases of N73D and W80F, the 
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affinity for E3 was reduced to half from WT, though that for Galβ1-4Fuc did not change 
significantly. This implies that these residues are involved in the interaction with a portion of 
E3 other than the Galβ1-4Fuc moiety. Collectively, these results indicate that a different 
binding mode exists when LEC-6 interacts with Galβ1-4Fuc instead of Galβ1-4GlcNAc.  
 
C. elegans galectin LEC-1 also binds Galβ1-4Fuc preferentially 
The above observation that Galβ1-4Fuc is the endogenous disaccharide unit recognized by 
LEC-6 raised a possibility that other C. elegans galectins also recognize the same unit. 
Therefore, we examined LEC-1, which is another major galectin, and moreover, the first 
galectin found from C. elegans. It was first isolated by affinity chromatography on 
immobilized asialofetuin and has been extensively studied (Hirabayashi, Satoh, Ohyama and 
Kasai, 1992; Hirabayashi, Satoh and Kasai, 1992; Arata et al., 2001). Here, we performed 
FAC analysis using an immobilized recombinant LEC-1 column, and the results are shown in 
Fig. 6A. Significant retardation was observed for PA-Galβ1-4Fuc, PA-Galβ1-3Fuc, and 
PA041 (PA-Galβ1-4GlcNAcβ1-3Galβ1-4Glc). The Ka and Kd values calculated are shown in 
Fig. 6B. It is evident that LEC-1 also preferentially recognizes β1-4-linked Gal-Fuc. Affinities 
for Galβ1-3Fuc or Galβ1-4GlcNAc (present in PA041) were weaker. Inhibition of 
hemagglutination caused by LEC-1 was also examined (Fig. 6C). The observed minimum 
concentrations required for inhibition were as follows: Galβ1-4Fuc, 1.25 mM; Galβ1-3Fuc, 
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5.0 mM; Galβ1-4Glc, 2.5 mM. Galβ1-4Fuc was found to be more effective than Galβ1-3Fuc 
and Galβ1-4Glc as an inhibitor. Therefore, LEC-1 also exhibited preferential recognition of 
Galβ1-4Fuc. 
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Discussion 
In the present study, we showed that the major C. elegans galectins LEC-6 and LEC-1 prefer 
Galβ1-4Fuc to Galβ1-4GlcNAc. Since the existence of glycan having multiple 
N-acetyllactosamine units, which is the endogenous unit recognized by vertebrate galectins, 
has not been confirmed in C. elegans glycoconjugates (Guerardel et al., 2001; Cipollo et al., 
2005; Griffitts et al., 2005; Hanneman et al., 2006; Paschinger et al., 2008), these results 
suggest that Galβ1-4Fuc is the endogenous glyco-epitope for C. elegans galectins instead of 
Galβ1-4GlcNAc. The existence of the Galβ1-4Fuc unit has already been reported in nematode, 
squid, octopus, and keyhole limpet (Zhang et al., 1997; Takahashi et al., 2003; Wuhrer et al., 
2004; Hanneman et al., 2006; Gutternigg et al., 2007), i.e., species belonging to Protostomia. 
This implies that the Galβ1-4Fuc disaccharide unit may be used as a common glyco-epitope 
for galectins or galectin-like lectins in the organisms belonging to Protostomia, although no 
report has appeared so far that showed the existence of galectins in these species except for 
nematode. 
 Since Galβ1-4Fuc is structurally different from Galβ1-4GlcNAc, the binding site of 
LEC-6 may also be different from those of vertebrate galectins in order to accommodate the 
former. However, the 8 conserved amino acid residues of galectins thought to be important for 
the recognition of Galβ1-4GlcNAc are also present in LEC-6 (Nemoto-Sasaki et al., 2008). In 
the present research using LEC-6 point mutants, these residues were also found important for 
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binding of Galβ1-4GlcNAc by both asialofetuin-binding assay and FAC analysis. On the 
other hand, some of them proved to be unnecessary for the binding of Galβ1-4Fuc. Since 
His60, Asn62, Arg64, Asn73, Trp80, and Glu83 of LEC-6 were thought to be necessary for 
the interaction with the Gal moiety (See, Fig. 3B), substitution of these 6 residues was 
expected to result in reduction in binding not only of Galβ1-4GlcNAc but also of Galβ1-4Fuc. 
However, N62D, N73D, and W80F mutant proteins retained the ability to recognize 
Galβ1-4Fuc, though some extent of reduction in binding affinity for E3 was observed in the 
cases of N73D and W80F mutant proteins. Among residues supposed to be responsible for the 
recognition of the GlcNAc moiety of N-acetyllactosamine, Val71 was found to be 
nonessential for the recognition of Galβ1-4Fuc. Significant reduction in Galβ1-4GlcNAc 
recognition was observed for all mutant proteins.  
On the basis of these results, Galβ1-4Fuc seems to be accommodated in the binding 
site of LEC-6 in a mode somewhat different from Galβ1-4GlcNAc, though the influence of 
substitution of residues on the conformation of the binding site should not be neglected, and 
we have no information on the conformation of Galβ1-4Fuc docked in the binding site. We 
are undertaking X-ray crystallography of the complex between LEC-6 and Galβ1-4Fuc. It 
should also be noted that Asp62 and Val71 of LEC-6, which seem to be necessary for the 
recognition of Galβ1-4GlcNAc, but are not required for the binding of Galβ1-4Fuc and E3, 
are relatively less conserved in C. elegans galectins in comparison with the other 6 highly 
16 
 
conserved residues (Nemoto-Sasaki et al., 2008). 
 LEC-1 was also found to bind Galβ1-4Fuc more strongly than Galβ1-4GlcNAc. 
However, the binding strength of LEC-1 for Galβ1-4Fuc was 4 times lower than that of 
LEC-6, and E3, an oligosaccharide isolated as an endogenous ligand N-glycan of LEC-6 
having a Galβ1-4Fuc disaccharide unit linked to position 6 of innermost GlcNAc, was poorly 
recognized by LEC-1 (unpublished result). Therefore, it seems that the structures of 
endogenous ligand oligosaccharides of LEC-1 are not the same as those of LEC-6. Isolation 
and identification of the endogenous ligand glycans of LEC-1 are in progress. 
 There exists a variety of differences between structures of glycans of C. elegans and 
those of vertebrates. Although no evidence of the presence of glycans containing the 
Galβ1-4GlcNAc units in C. elegans has been presented so far (Schachter, 2004; Cipollo et al., 
2005; Paschinger et al., 2008,), C. elegans galectins actually retain Galβ1-4GlcNAc-binding 
ability (Hirabayashi et al., 2002; Nemoto-Sasaki et al., 2008). This property enabled us to 
discover galectins from C. elegans, because we first isolated LEC-1 and LEC-6 from the 
worm body using asialofetuin Sepharose (Hirabayashi, Satoh, Ohyama and Kasai, 1992; 
Hirabayashi, Satoh and Kasai, 1992; Hirabayashi et al., 1996). In the present study, we 
showed that the C. elegans galectins LEC-6 and LEC-1 recognize Galβ1-4Fuc more strongly 
than Galβ1-4GlcNAc, and the mechanism of this recognition seems to be different from that 
of the recognition of Galβ1-4GlcNAc. These observations suggest the occurrence of 
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co-evolution between C. elegans glycans and galectins. Structures of C. elegans glycans have 
been altered during their evolutional process in a way different from those of vertebrates. 
Animals belonging to Protostomia acquired Galβ1-4Fuc, but those belonging to 
Deuterostomia acquired Galβ1-4GlcNAc as the unit of recognition for galectins. Because 
fungi and sponges have galectins (Cooper, 2002), ancestors of the galectin family should have 
existed before the divergence of Protostomia and Deuterostomia. After the divergence, 
Protostomia galectins and Deuterostomia galectins seem to have evolved in order to more 
efficiently accommodate Galβ1-4Fuc and Galβ1-4GlcNAc, respectively. If this is true, the 
importance of the galectin-glycan interaction has never declined in Protostomia and 
Deutrostomia in spite of alterations in the glycan structure. Therefore, research on the 
galectins of Drosophila melanogaster (another species in which galectins were found) and 
their endogenous glyco-epitopes seems to be important (Pace et al., 2002; Pace and Baum, 
2004). Synthesized Galβ1-4Fuc and PA-Galβ1-4Fuc should be very useful tools for further 
research on the sugar recognition phenomena occuring in Protostomia. 
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Materials and methods 
Materials  
Galactoseβ1-4Fucose (Galβ1-4Fuc), Galactoseβ1-3Fucose (Galβ1-3Fuc), Galβ1-4Fuc labeled 
with pyridylamine via a spacer (PA-Galβ1-4Fuc), and Galβ1-3Fuc labeled with pyridylamine 
via a spacer (PA-Galβ1-3Fuc) were chemically synthesized (details regarding the synthesis 
will appear elsewhere). Their structures were confirmed by 1H-NMR analyses. 
 
Construction of a recombinant LEC-6 expression plasmid 
The open reading frame of LEC-6 containing the BamHI and XhoI sites was amplified by a 
polymerase chain reaction (PCR) using 5′-GGATCCATGATCGGAGGAGGAAT-3′ as the 
forward primer and 5′-CTCGAGTTAGTGAGAAACATGGG-3′ as the reverse primer. The 
PCR fragment thus obtained was cloned into the XcmI-digested pGEM-TX plasmid generated 
by inserting the double-strand DNA fragment that was composed of 
5′-TACCATATGTTAACTGGGGAGTCGACGCCCCAGCTGACTAGTGG-3′ and 
5′-CATGCCACTAGTCAGCTGGGGCGTCGACTCCCCAGTTAACATATGG-3′ into the 
NcoI and NdeI sites of the pGEM-T plasmid (Promega, Madison, WI, USA). The 
pGEM-TX-LEC-6 plasmid was then digested with BamHI and XhoI, and the DNA fragment 
thus obtained was inserted into the BamHI and XhoI sites of the pET-FLAG vector (Takeuchi, 
Sennari et al., 2008). Point mutants of LEC-6 were generated by PCR using the 
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pGEM-LEC-6 plasmid and the following primers (substitution sites are underlined): H60F, 5′- 
TTCTTCAACGCTAGATTCGATG-3′ and 5′-AAGAACAATGTCGTCTGGAGTG-3′; N62D, 
5′-GACGCTAGATTCGATGAGGG-3′ and 5′-GAAGTGAAGAACAATGTCGTC-3′; R64H, 
5′-CACTTCGATGAGGGAGCTGTTG-3′ and 5′-AGCGTTGAAGTGAAGAACAATG-3′; 
V71A, 5′-GCGAACAACTCGACCAGCGG-3′ and 5′-AACAGCTCCCTCATCGAATC-3′; 
N73D, 5′-GACTCGACCAGCGGAGGAGG-3′ and 5′-GTTCACAACAGCTCCCTCATC-3′; 
W80F, 5′-TTCCAATCCGAGGATCGTCAC-3′ and 5′-ACCTCCTCCGCTGGTCGAGT-3′; 
E83Q, 5′-CAGGATCGTCACGCCAAT-3′ and 5′-GGATTGCCAACCTCCTCC-3′; R85H, 
5′-ATCACGCCAATCCATTCCAG-3′ and 5′-GATCCTCGGATTGCCAAC-3′. Insert DNA 
fragment of the pGEM-LEC-6 point mutant plasmid was then subcloned into the pET-FLAG 
vector.  
 
Expression and affinity purification of recombinant galectins on asialofetuin-Sepharose 
Escherichia coli strain BL21 (DE3) transformed with a FLAG-tagged LEC-6 expression 
plasmid was cultured overnight at 37°C in LBA medium (Luria-Bertani medium 
supplemented with 50 μg/ml of ampicillin), transferred to a 25-fold volume of 2×YT medium 
containing 50 μg/ml of ampicillin, and then incubated at 37°C for 3 h. Following chilling in 
ice-cold water, isopropyl-1-thio-β-D-galactopyranoside was added to the culture at a final 
concentration of 0.2 mM and the culture was further incubated overnight at 20°C. The cells 
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were then harvested and suspended in phosphate-buffered saline-EDTA (PBS-EDTA; 8.1 mM 
Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.68 mM KCl, pH 7.4, supplemented with 2 
mM EDTA) and then lysed by sonication. Following centrifugation of the lysate, the 
recombinant LEC-6 contained in the supernatant was adsorbed on asialofetuin-Sepharose 
packed in a column (bed volume 7ml for LEC-6 WT, N62D, E83Q, and R85H; bed volume 
10 ml for the other mutants) prepared as described previously (Arata et al., 1997). The 
adsorbed protein was eluted with PBS-Lac (PBS-EDTA containing 0.1 M lactose). These 
purification procedures were performed at 4°C. The fraction volume was set to 6 mL 
throughout the experiment. Each fraction was subjected to SDS-PAGE and stained with 
Bio-Safe™ Coomassie (BIO-RAD, Hercules, CA, USA). The protein concentration of each 
fraction was determined using a BIO-RAD Protein Assay (BIO-RAD) with bovine serum 
albumin as the standard. For the preparation of immobilized mutant LEC-6 columns, the 
following fractions of asialofetuin affinity chromatography (Fig. 4) were recovered: WT, Fr. 
14 and 15; H60F, Fr. 5–7; N62D, Fr. 14 and 15; V71A, Fr. 5–8; N73D, Fr. 4 and 5; W80F, Fr. 
6–10; E83Q, Fr. 5 and 6; R85H, Fr. 6 and 7. Expression and purification of recombinant 
LEC-1 protein was performed basically as described above, with the exception that the 
pET-LEC-1 plasmid (Arata et al., 1997) was used for transformation of E. coli, and LBA 
medium was used instead of 2×YT medium. 
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Frontal affinity chromatography analysis 
Immobilization of recombinant galectins on HiTrap NHS-activated Sepharose (GE Healthcare, 
St. Giles, UK) and FAC analysis were performed basically as described previously (Takeuchi, 
Hayama et al., 2008). In brief, each PA-sugar at a concentration of 5 nM was applied to an 
immobilized galectin column (1.6 mg LEC-6, 5.4 mg LEC-6 H60F, 1.6 mg LEC-6 N62D, 7.2 
mg LEC-6 V71A, 8.2 mg LEC-6 N73D, 6.4 mg LEC-6 W80F, 3.6 mg LEC-6 E83Q, 6.6 mg 
LEC-6 R85H, or 11.7 mg LEC-1 protein/mL gel) at a flow rate of 0.25 mL/min at 20 °C, and 
the elution profile was monitored by a fluorescence detector. The Kd value for the interaction 
between galectin and PA-sugar was determined according to the following basic equation of 
FAC: Kd = Bt/(Vf – V0) – [A]0. In this equation, Bt is the effective ligand content, Vf is the 
volume of the elution front, V0 is the Vf of PA-rhamnose that is not bound by LEC-6 and 
LEC-1, and [A]0 is the initial concentration of the PA-sugar. If the [A]0 is negligibly smaller 
than Kd, the equation can be simplified as Kd = Bt/(Vf – V0). In this study, the Bt value of each 
immobilized galectin column was calculated from the data obtained by 
concentration-dependence analysis with various concentrations of Galβ1-4Fuc, and that of 
LEC-1 column was calculated from the reported Kd values for the interaction between LEC-1 
and PA041 (See below) (Arata et al., 2001). The Ka values were calculated based on the 
equation, Ka = 1/Kd. PA-oligosaccharides used are as follows. PA001 (NA2, 
Galβ1-4GlcNAcβ1-2Manα1-3(Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcAc-P
22 
 
A), PA002 (NA3, 
Galβ1-4GlcNAcβ1-2(Galβ1-4GlcNAcβ1-4)Manα1-3(Galβ1-4GlcNAcβ1-2Manα1-6)Manβ1-
4GlcNAcβ1-4GlcNAc-PA), PA004 (NA4, 
Galβ1-4GlcNAcβ1-2(Galβ1-4GlcNAcβ1-4)Manα1-3(Galβ1-4GlcNAcβ1-2(Galβ1-4GlcNAc
β1-6)Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAc-PA), PA041 
(Galβ1-4GlcNAcβ1-3Galβ1-4Glc-PA). These PA-oligosaccharides and PA-rhamnose were 
purchased from Takara Bio (Shiga, Japan). E3, a pyridylaminated endogenous ligand 
N-glycan of LEC-6, was isolated from C. elegans as reported previously (Takeuchi, Hayama 
et al., 2008). 
Hemagglutination assay 
Rabbit erythrocytes (Nippon Biotest Labo, Tokyo, Japan) were treated with trypsin and then 
with glutaraldehyde. The erythrocytes were then washed with phosphate-buffered saline 
(PBS) containing 0.1 M glycine, after which they were extensively washed with Tris-buffered 
saline (TBS; 20 mM Tris-HCl, pH 7.5, and 150 mM NaCl). To examine the ability of the 
competitive sugars to inhibit the hemagglutination activity of galectins, an appropriate 
concentration of galectin (25 μg/mL LEC-6 or 12.5 μg/mL LEC-1), 50 μg/mL of bovine 
serum albumin, 1% (v/v) rabbit erythrocytes, and two times serially diluted 
competitive-sugars (at a final concentration of 0.005–10 mM) were mixed in 100 μL of TBS 
in a 96-well V-shaped titer plate, and then incubated at room temperature for 1 h. 
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Legends to Figures 
Figure 1. Structures of chemically synthesized PA-sugars 
The structures of Galβ1-4Fuc and Galβ1-3Fuc labeled with 2-aminopyridyne (PA) via a 
spacer derived from mannitol are depicted. These conformations are based on 1H-NMR 
spectra. (A) PA-Galβ1-4Fuc. (B) PA-Galβ1-3Fuc. 
 
Figure 2. Frontal affinity chromatography analysis of PA-sugars containing Gal-Fuc on an 
immobilized LEC-6 column and hemagglutination inhibition assay of disaccharides 
(A) Elution profiles of the PA-sugars from an immobilized LEC-6 column. The structure of 
each PA-sugar is depicted in each panel of elution profile. Open circle with diagonal line, 
hexose; open circle, mannose; filled circle, galactose; filled square, N-acetylglucosamine; 
open triangle, fucose. The elution profile of each PA-sugar (solid line) was superimposed on 
that of PA-rhamnose (broken line) which has no affinity for LEC-6. (B) The Ka and Kd values 
for the interaction between LEC-6 and PA-sugars were calculated as described in Materials 
and Methods. (C) Inhibition of the hemagglutination activity of LEC-6 by competitive sugars. 
The final concentration of LEC-6 was fixed at 25 μg/mL. Competitive sugars were added to 
each well at varying concentration. The final concentrations of competitive sugars are 
indicated. 
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Figure 3. Alignment of human galectin-1 and LEC-6 and comparison of the structures of 
Galβ1-4Glc with Galβ1-4Fuc 
(A) Alignment of amino acid sequences of human galectin-1 (hGal-1) and LEC-6. The three 
amino acids (N46, E71, and R73 corresponding to N62, E83, R85 of LEC-6, respectively) 
that were demonstrated to be essential for sugar binding function of hGal-1 (Hirabayashi and 
Kasai, 1991) are denoted by closed arrowheads. The 8 amino acids (H, N, R, V, N, W, E, and 
R) conserved among proteins belonging to the galectin family are denoted by closed circles. 
Conserved or homologous amino acids are denoted by asterisks. The initiating methionine 
residue is not contained in amino acid sequence of hGal-1, because the residue of hGal-1 has 
been proved to be processed in its mature form (Hirabayashi and Kasai, 1988), and for 
consistency with the previous report (Hirabayashi and Kasai, 1991). (B) A simulated model of 
interaction between Galβ1-4Glc and the binding site of LEC-6 modified from the report on 
the crystallography of human galectin-2 and the Galβ1-4Glc complex (Lobsanov et al., 1993). 
Hydrogen bonds are denoted by broken lines. Van der Waals interactions are denoted by grey 
circles. (C) Galβ1-4Fuc depicted on the assumption that it takes the same conformation as that 
of Galβ1-4Glc docked in the binding site. 
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Figure 4. Results of affinity chromatography of point mutant recombinant LEC-6 proteins on 
an asialofetuin-Sepharose column 
Recombinant LEC-6 protein was expressed in E. coli BL21 (DE3), and the cells were then 
disrupted. After centrifugation, the supernatant fraction was applied to an 
asialofetuin-Sepharose column (bed volume 7 ml for WT, N62D, E83Q, and R85H; bed 
volume 10 ml for the other mutants). After the column was washed with PBS-EDTA, the 
adsorbed protein was eluted with 0.1 M lactose. Successive 6 mL fractions were collected and 
subjected to SDS-PAGE. (A) Wild type. (B) H60F. (C) N62D. (D) R64H. (E) V71A. (F) 
N73D. (G) W80F. (H) E83Q. (I) R85H. Recombinant LEC-6 proteins are indicated by 
arrowheads. 
 
Figure 5. FAC analysis of PA-sugars on columns immobilized with WT and point mutants 
LEC-6 
(A) Structures of the PA-sugars examined by FAC analysis. Symbols are as in Figure 2. (B) 
The Ka values for the interaction between LEC-6 and PA-sugars. ND indicates not determined, 
because no retardation was observed and it was unable to calculate. 
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Figure 6. FAC analysis of PA-sugars on an immobilized LEC-1 column and the ability of 
sugars to inhibit hemagglutination caused by LEC-1 
(A) Elution profiles of the PA-sugars. The structure of each PA-sugar is depicted in each 
elution profile. Symbols are as in Figure 2, and grey circles indicate glucose residue. The 
elution profile of each PA-sugar (solid line) was superimposed on that of PA-rhamnose 
(broken line). (B) The Ka and Kd values for the interaction between LEC-1 and PA-sugars. (C) 
Inhibition of hemagglutination activity of LEC-1 by competitive sugars. Final concentration 
of LEC-1 was fixed at 12.5 μg/mL; final concentrations of competitive sugars are indicated.  
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Table I. Summary of the Kd values (μM) between PA-sugars and LEC-6 wild type (WT) or its 
point mutants, determined by frontal affinity chromatography 
 
  NA2 NA3 NA4 E3 Galβ1-4Fuc 
WT 37.8  19.1  16.1  6.9  17.9  
H60F ND ND ND ND ND 
N62D 155.7  83.1  80.1 7.6  22.7  
V71A 752.7  74.8  68.8 6.7  22.3  
N73D ND ND ND 15.0  21.4  
W80F 172.0  66.2  57.3 12.7  32.1  
E83Q ND ND ND ND ND 
R85H 892.0  341.8  382.7 42.8  24.4  
ND indicates not determined because of no retardation.   
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